Human Secretory Phospholipase A2Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice
- 1 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (7), 1213-1218
- https://doi.org/10.1161/01.atv.0000023228.90866.29
Abstract
Objective— Plasma levels of high density lipoprotein (HDL) cholesterol and apolipoprotein (apo)A-I are decreased in inflammatory states. Secretory phospholipase A2 (sPLA2), an acute-phase protein, ...Keywords
This publication has 27 references indexed in Scilit:
- Phospholipases A2Seminars in Cell & Developmental Biology, 1997
- Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levelsNature, 1997
- Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal modelsCurrent Opinion in Lipidology, 1996
- The mortality of rheumatoid arthritisArthritis & Rheumatism, 1994
- Effects of endotoxin and cytokines on lipid metabolismCurrent Opinion in Lipidology, 1994
- Serum amyloid A (SAA): an acute phase protein and apolipoproteinAtherosclerosis, 1993
- Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AINature, 1991
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Serum amyloid A and high density lipoproteins during the acute phase responseEuropean Journal of Clinical Investigation, 1988
- Further studies on serum lipoproteins in connective tissue diseasesAtherosclerosis, 1978